Studies have shown that the immediate initiation of inhaled triple therapy with a single inhaler immediately after a COPD exacerbation achieves better therapeutic effects than delayed initiation. However, Canadian scientists have now found that these studies contain systematic time-related bias.
Autoren
- Jens Dehn
Publikation
- InFo PNEUMOLOGIE & ALLERGOLOGIE
Related Topics
You May Also Like
- Psoriasis Research: What's in the Pipeline?
Highly selective oral TYK inhibitors in Phase III
- Cardiometabolism
Retatrutid and the TRIUMPH Program: The Triple Agonist on the Horizon
- Pediatric Retinoblastoma
The Tumor Microenvironment and Modern Eye-Sparing Therapies
- Adherence and management in asthma and COPD
Better to listen to the pharmacist
- Focus Update 2026
Echocardiography in Cardio-Oncology
- Physical activity with IBD
Sport is not murder, but it doesn’t help either
- White and Black Skin Cancer
Biology and Modern Therapeutic Approaches
- Highlights from the AAD Annual Meeting